Rickels Kaersti L, Chauhan Muhammad Z, Dagi Linda R, Rageh Abdulrahman, Oke Isdin, Phillips Paul H, Elhusseiny Abdelrahman M
Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences (UAMS) Medical Center, Little Rock, Arkansas.
Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Ophthalmol Sci. 2025 Jul 23;5(6):100892. doi: 10.1016/j.xops.2025.100892. eCollection 2025 Nov-Dec.
To evaluate the cumulative incidence of strabismus in childhood glaucoma and compare its risk to that in healthy controls.
A retrospective clinical cohort study.
Childhood glaucoma patients aged ≤18 years from the TriNetX US Collaborative Network.
Patients were identified using the International Classification of Diseases Ninth and 10th Revision codes. The primary study group included childhood glaucoma patients aged ≤18 years, while the control group consisted of healthy children with no history of ocular disorders. We analyzed the cumulative incidence of strabismus in both primary and secondary glaucoma. Propensity score matching (PSM) was used to compare the risk of strabismus between glaucoma and control groups. A Cox proportional hazards model was employed to identify predictors of strabismus among children with glaucoma.
The primary outcome was the cumulative incidence of strabismus at 1 and 5 years after glaucoma diagnosis. The secondary outcomes included (1) comparative risk of strabismus between glaucoma and control groups, (2) evaluating the rates of strabismus surgery in the glaucoma cohort, and (3) identifying the risk factors associated with strabismus development in the glaucoma group.
The study group included 12 637 patients, with a mean age at glaucoma diagnosis of 3.81 ± 4.44 years in the primary glaucoma group and 5.18 ± 4.40 years for the secondary glaucoma group. The cumulative incidence of strabismus in primary glaucoma was 9.19% at 1 year and 18.89% at 5 years. In secondary glaucoma, the cumulative incidence was 20.40% at 1 year and 31.39% at 5 years. After PSM, the 5-year risk of strabismus was significantly higher in the glaucoma group compared with controls (adjusted hazard ratio [aHR]: 7.95; 95% confidence interval [CI]: 5.67-11.14; <0.01 for primary glaucoma and aHR: 14.51; 95% CI: 12.59-16.72; <0.01 for secondary childhood glaucoma). Risk factors for strabismus development in the glaucoma group included younger age at secondary glaucoma diagnosis, nystagmus, and amblyopia.
Childhood glaucoma is associated with a significantly increased risk of developing strabismus compared with healthy controls. Within the glaucoma group, younger age (in secondary glaucoma), nystagmus, amblyopia, and glaucoma surgery were all associated with an increased risk of strabismus.
The authors have no proprietary or commercial interest in any materials discussed in this article.
评估儿童青光眼斜视的累积发病率,并将其风险与健康对照者进行比较。
一项回顾性临床队列研究。
来自TriNetX美国协作网络的18岁及以下儿童青光眼患者。
使用国际疾病分类第九版和第十版编码识别患者。主要研究组包括18岁及以下儿童青光眼患者,而对照组由无眼部疾病史的健康儿童组成。我们分析了原发性和继发性青光眼斜视的累积发病率。采用倾向评分匹配(PSM)比较青光眼组和对照组之间斜视的风险。采用Cox比例风险模型确定青光眼患儿斜视的预测因素。
主要结局是青光眼诊断后1年和5年斜视的累积发病率。次要结局包括:(1)青光眼组和对照组之间斜视的比较风险;(2)评估青光眼队列中斜视手术的发生率;(3)确定青光眼组中与斜视发生相关的危险因素。
研究组包括12637例患者,原发性青光眼组青光眼诊断时的平均年龄为3.81±4.44岁,继发性青光眼组为5.18±4.40岁。原发性青光眼斜视的累积发病率在1年时为9.19%,5年时为18.89%。继发性青光眼1年时累积发病率为20.40%,5年时为31.39%。PSM后,青光眼组5年斜视风险显著高于对照组(调整后风险比[aHR]:7.95;95%置信区间[CI]:5.67-11.14;原发性青光眼P<0.01,继发性儿童青光眼aHR:14.51;95%CI:12.59-16.72;P<0.01)。青光眼组斜视发生的危险因素包括继发性青光眼诊断时年龄较小、眼球震颤和弱视。
与健康对照者相比,儿童青光眼发生斜视的风险显著增加。在青光眼组中,年龄较小(继发性青光眼)、眼球震颤、弱视和青光眼手术均与斜视风险增加相关。
作者对本文讨论的任何材料均无所有权或商业利益。